EndoTheia's Innovative Steerable Kidney Stone Basket: A First-In-Human Study

Tuesday, 19 November 2024, 13:26

EndoTheia has completed the first-in-human study of its innovative steerable kidney stone treatment, the FlexStone basket. This advancement represents a significant breakthrough in kidney stone management. The trial underscores EndoTheia's commitment to enhancing patient outcomes through technology.
Massdevice
EndoTheia's Innovative Steerable Kidney Stone Basket: A First-In-Human Study

EndoTheia has announced today that it completed the first-in-human clinical trial for its FlexStone basket, a steerable kidney stone treatment. This innovation aims to improve the precision of kidney stone removal while reducing patient recovery time.

Key Features of the FlexStone Basket

  • Steerable design for enhanced maneuverability
  • Improved patient outcomes through targeted treatment
  • Reduces the need for invasive procedures

Clinical Trial Insights

The trial evaluated the safety and effectiveness of the FlexStone basket in real-world settings. Results showed promising potential for future applications in urology.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe